A Study to Assess Mass Balance, Pharmacokinetics, Metabolism, and Excretion of Emraclidine in Healthy Adult Male Participants
Clinical trial NCT06301971 · COMPLETED
Trial details
- NCT number
- NCT06301971
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-04
- Primary completion
- 2024-04-04
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.